Skip to main content

Notification · DGFT

NOTIFICATION NO. 72/2023, DT. 11/03/2024

Dated
11 Mar 2024
Reference no.
72/2023

Amendment in export Policy of Human Biological Samples under Chapter-30 of ITC HS schedule-2 of export policy.

[To be Published in the Gazette of India Extraordinary Part-II, Section - 3, Sub-Section (ii)] Ministry of Commerce & Industry
Department of Commerce
Directorate General of Foreign Trade
Vanijya Bhawan, New Delhi
Notification No. 2/2023

New Delhi, Dated: 2024

Subject: Amendment in export Policy of Human Biological Samples under Chapter-30 of ITC HS schedule-2 of export policy.

S.O. (E). — In exercise of powers conferred by Section 3 read with section 5 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para

1.02 and 2.01 of the Foreign Trade Policy, 2023, the Central Government hereby amends Export Policy under chapter 30 related to Human Biological Samples, as under:

HS CodeItem DescriptionRevised Export PolicyRevised Policy Condition
30021020Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesFree subject to NOC1. Any human biological which are related to activities covered under the provision of Drugs & Cosmetics Act 1940 & Rules thereunder are free for export subject to No objection from CDSCO. 2. Any human biological materials/samples/products NOT covered under (1) above are free for export subject to No objection from ICMR/DHR.
30021091Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
30021210For diphtheria
30021220For tetanus
30021230For rabies
30021240For snake venom
30021290Other
30029010Human Blood

2. Effect of the Notification:

Export Policy of Human Biological Samples under Chapter 30 of ITC HS schedule-2 of export policy is amended to the extent that export of item that contains Human biological materials/samples/products under chapter 30 is free subject to the NOC from Central Drugs Standard Control Organization (CDSCO) or Indian Council of Medical Research (ICMR), Department of Health Research (DHR).

v
bys
(Santosh Kumar Sarangi)

Director General of Foreign Trade
Ex-Officio Additional Secretary, Government of India
E-mail: dgft@nic.in
(Issued from F. No.

Source: Directorate General of Foreign Trade (DGFT). View the official PDF.